Brainstorm Cell Therapeutics, Inc. (BCLI)

1.00 +0.02 (+2.04%) USD  |  OTCM  |  Aug 24, 16:00
More

Brainstorm Cell Therapeutics Revenue Estimates for Current Quarter

Revenue Estimates for Current Quarter Chart

View Revenue Estimates for Current Quarter for BCLI.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Revenue Estimates for Current Quarter Chart
Start Trial

Historical Revenue Estimates for Current Quarter Data

View and export this data back to 2024. Start Trial.
Date Value
August 17, 2026 --
December 31, 2025 --
August 15, 2025 --
August 14, 2025 --
July 23, 2025 --
July 07, 2025 --
June 30, 2025 --
May 27, 2025 --
May 19, 2025 --
Date Value
April 04, 2025 --
March 31, 2025 --
December 31, 2024 --
September 30, 2024 --
August 14, 2024 --
July 11, 2024 --
July 10, 2024 --
June 30, 2024 --
April 11, 2024 --

Revenue Estimates for Current Quarter Range, Past 5 Years

View Revenue Estimates for Current Quarter Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Revenue Estimates for Current Quarter Benchmarks

View Revenue Estimates for Current Quarter Benchmarks
Start Trial
NovelStem International Corp. Upgrade
Summit Therapeutics, Inc. Upgrade
Kezar Life Sciences, Inc. Upgrade
Protara Therapeutics, Inc. Upgrade
Clene, Inc. Upgrade

Revenue Estimates for Current Quarter Related Metrics

EPS Estimates for Current Quarter Upgrade
EPS Estimates for Next Quarter Upgrade
EPS Estimates for Current Fiscal Year Upgrade
EPS Estimates for Next Fiscal Year Upgrade